Patients and the general public

As part of the National Multiple Myeloma Information Day (JNM 2022) of the AF3M (Association Française des Malades du Myélome Multiple), the association has released a new information bulletin [...]

On Saturday 15 October, SIRIC ILIAD was present at the National Information Day on Multiple Myeloma (JNM 2022) of the AF3M (French Association of Multiple Myeloma Patients) in Nantes. For the [...]

What if acting on the cells surrounding the tumour could improve the effectiveness of treatments? On 14 September 2022, a team from the SIRIC ILIAD specialising in breast cancer published a [...]

The SIRIC ILIAD Partners Committee met on Monday 17 October 2022 to present the results of the 5 years of labelling. A week ago, the fifth meeting of the SIRIC ILIAD Partners Committee took place [...]

The French National Cancer Institute is organising a day of debate and exchange for the general public on the issue of maintaining and returning to work for people affected by cancer: [...]

Since May 2022, Sara Gandolfi has joined the ranks of the SIRIC ILIAD teams as a post-doctoral researcher. She has joined team 11 of the CRCI²NA, to study a bone marrow cancer, multiple myeloma. [...]

What if managers’ emotional skills could help improve employees’ return to work after cancer? Marie Viseux, a doctoral student in the SIRIC ILIAD’s ReWork programme, has [...]

The SIRIC ILIAD, the Cancéropôle Grand Ouest (CGO) and the patient association Europa Donna are organising an event for the general public on breast cancer and diet as part of Pink October, on [...]

In May 2022, Marc Fadel, head of clinic at the CHU of Angers, joined the ReWork team of the SIRIC ILIAD, co-directed by Prof. Yves Roquelaure, to study work-related cancer pathologies. A few [...]

Is physical activity a lever for a return to work after cancer? This question was the subject of a study conducted by researchers from the SIRIC ILIAD ReWork programme, whose results were [...]